These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 27705797)

  • 1. S6K1 Is Required for Increasing Skeletal Muscle Force during Hypertrophy.
    Marabita M; Baraldo M; Solagna F; Ceelen JJM; Sartori R; Nolte H; Nemazanyy I; Pyronnet S; Kruger M; Pende M; Blaauw B
    Cell Rep; 2016 Oct; 17(2):501-513. PubMed ID: 27705797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic paraplegia-induced muscle atrophy downregulates the mTOR/S6K1 signaling pathway.
    Dreyer HC; Glynn EL; Lujan HL; Fry CS; DiCarlo SE; Rasmussen BB
    J Appl Physiol (1985); 2008 Jan; 104(1):27-33. PubMed ID: 17885021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endotoxin disrupts the leucine-signaling pathway involving phosphorylation of mTOR, 4E-BP1, and S6K1 in skeletal muscle.
    Lang CH; Frost RA
    J Cell Physiol; 2005 Apr; 203(1):144-55. PubMed ID: 15389631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of caffeine on skeletal muscle anabolic signaling and hypertrophy.
    Moore TM; Mortensen XM; Ashby CK; Harris AM; Kump KJ; Laird DW; Adams AJ; Bray JK; Chen T; Thomson DM
    Appl Physiol Nutr Metab; 2017 Jun; 42(6):621-629. PubMed ID: 28177708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy.
    Chen JK; Chen J; Thomas G; Kozma SC; Harris RC
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F585-93. PubMed ID: 19474189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway.
    Altamirano F; Oyarce C; Silva P; Toyos M; Wilson C; Lavandero S; Uhlén P; Estrada M
    J Endocrinol; 2009 Aug; 202(2):299-307. PubMed ID: 19474060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Akt signalling through GSK-3beta, mTOR and Foxo1 is involved in human skeletal muscle hypertrophy and atrophy.
    Léger B; Cartoni R; Praz M; Lamon S; Dériaz O; Crettenand A; Gobelet C; Rohmer P; Konzelmann M; Luthi F; Russell AP
    J Physiol; 2006 Nov; 576(Pt 3):923-33. PubMed ID: 16916907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrulline directly modulates muscle protein synthesis via the PI3K/MAPK/4E-BP1 pathway in a malnourished state: evidence from in vivo, ex vivo, and in vitro studies.
    Le Plénier S; Goron A; Sotiropoulos A; Archambault E; Guihenneuc C; Walrand S; Salles J; Jourdan M; Neveux N; Cynober L; Moinard C
    Am J Physiol Endocrinol Metab; 2017 Jan; 312(1):E27-E36. PubMed ID: 27827806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins.
    Wang X; Beugnet A; Murakami M; Yamanaka S; Proud CG
    Mol Cell Biol; 2005 Apr; 25(7):2558-72. PubMed ID: 15767663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The type 1 insulin-like growth factor receptor (IGF-IR) pathway is mandatory for the follistatin-induced skeletal muscle hypertrophy.
    Kalista S; Schakman O; Gilson H; Lause P; Demeulder B; Bertrand L; Pende M; Thissen JP
    Endocrinology; 2012 Jan; 153(1):241-53. PubMed ID: 22087027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct role of 4E-BP1 and S6K1 in regulating autophagy and hepatitis B virus (HBV) replication.
    Gao Q; Hou B; Yang H; Jiang X
    Life Sci; 2019 Mar; 220():1-7. PubMed ID: 30690083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sepsis attenuates the anabolic response to skeletal muscle contraction.
    Steiner JL; Lang CH
    Shock; 2015 Apr; 43(4):344-51. PubMed ID: 25423127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol impairs leucine-mediated phosphorylation of 4E-BP1, S6K1, eIF4G, and mTOR in skeletal muscle.
    Lang CH; Frost RA; Deshpande N; Kumar V; Vary TC; Jefferson LS; Kimball SR
    Am J Physiol Endocrinol Metab; 2003 Dec; 285(6):E1205-15. PubMed ID: 12944322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key Markers of mTORC1-Dependent and mTORC1-Independent Signaling Pathways Regulating Protein Synthesis in Rat Soleus Muscle During Early Stages of Hindlimb Unloading.
    Mirzoev T; Tyganov S; Vilchinskaya N; Lomonosova Y; Shenkman B
    Cell Physiol Biochem; 2016; 39(3):1011-20. PubMed ID: 27536969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of ribosomal protein S6 mediates compensatory renal hypertrophy.
    Xu J; Chen J; Dong Z; Meyuhas O; Chen JK
    Kidney Int; 2015 Mar; 87(3):543-56. PubMed ID: 25229342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restorative Mechanisms Regulating Protein Balance in Skeletal Muscle During Recovery From Sepsis.
    Crowell KT; Soybel DI; Lang CH
    Shock; 2017 Apr; 47(4):463-473. PubMed ID: 27749759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual inhibition by S6K1 and Elf4E is essential for controlling cellular growth and invasion in bladder cancer.
    Kyou Kwon J; Kim SJ; Hoon Kim J; Mee Lee K; Ho Chang I
    Urol Oncol; 2014 Jan; 32(1):51.e27-35. PubMed ID: 24239466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
    Khamzina L; Veilleux A; Bergeron S; Marette A
    Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
    Liu L; Li F; Cardelli JA; Martin KA; Blenis J; Huang S
    Oncogene; 2006 Nov; 25(53):7029-40. PubMed ID: 16715128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscle-specific 4E-BP1 signaling activation improves metabolic parameters during aging and obesity.
    Tsai S; Sitzmann JM; Dastidar SG; Rodriguez AA; Vu SL; McDonald CE; Academia EC; O'Leary MN; Ashe TD; La Spada AR; Kennedy BK
    J Clin Invest; 2015 Aug; 125(8):2952-64. PubMed ID: 26121750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.